Company also declares preferred stock dividends Synchrony Financial (NYSE: SYF) announced today that its Board of Directors declared a quarterly cash dividend of $0.30 per share of common stock, payable on November17,2025, to holders of record at the close of business on November 5, 2025. https://mma.prnewswire.com/media/804087/synchrony.jpg The Board of Directors also declared a quarterly cash […]
Robo.ai Inc. (Nasdaq: AIIO) (the “Company”), a technology company headquartered in the United Arab Emirates, today announced that each of the proposed resolutions submitted for shareholder approval as set forth in the notice of extraordinary general meeting of shareholders dated October 8, 2025 (the “EGM Notice”) has been adopted at its extraordinary general meeting of
Quarter Highlights — Net Income Attributable to Common Stockholders of $1.26 Per Diluted Share for Third Quarter 2025 Compared to $1.13 Per Diluted Share for Third Quarter 2024 — Funds from Operations (“FFO”) of $2.27 Per Diluted Share for Third Quarter 2025 Compared to $2.13 Per Diluted Share for Third Quarter 2024, an Increase of
The last day of trading will be November 17, 2025 Upon the recommendation of Sterling Capital Management LLC, the Board of Trustees of the Northern Lights Fund Trust IV (the “Board”) has authorized an orderly liquidation of the Focus Equity ETF (NYSE Arca: LCG; the “Fund”). After careful consideration of a number of factors, including
(NasdaqGM:RANI), SAN JOSE, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral delivery of biologics and drugs, today announced the appointment of Abraham (“Abe”) Bassan and Vasudev Bailey, Ph.D., to its Board of Directors. In conjunction with the new
(NYSE:USBC), RENO, Nev., Oct. 23, 2025 (GLOBE NEWSWIRE) — USBC, Inc. (NYSE American: USBC) (“USBC” or the “Company”), an industry-leading, publicly traded technology company that enables the transformation of traditional U.S. bank dollars into secure, compliant tokenized deposits, today announced a preliminary partnership with Uphold, the infrastructure provider for on-chain finance, and nationally-chartered Vast Bank
(NasdaqGM:BBOT), Data demonstrate potent suppression of MAPK signaling and viability in KRAS mutant cell lines, as well as anti-tumor activity across multiple KRASG12D and KRASG12V cell-derived xenograft (CDX) models BBO-11818's selectivity for KRAS demonstrated by its >1000-fold lower potency against NRAS, HRAS, and BRAF-mutant cell lines Efficacy of the combination with BBOT's RAS:PI3K⺠breaker, BBO-10203,
(Other OTC:MSWV),(OTC US:MSWV), Business Highlights Net income increased for the third quarter by 32%, totaling $4.5 million, or $0.58 per common share, compared to $3.4 million, or $0.44 per common share, for the third quarter of 2024. Return on average assets (ROA) improved 25 basis points to 1.25%, compared to 1.00% in the third quarter
(NasdaqGM:IOVA), SAN CARLOS, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) — Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, will report its third quarter 2025 financial results and corporate updates before market on Thursday, November 6, 2025. Management will
(NASDAQ:AGCC), Taiwan, Oct. 23, 2025 (GLOBE NEWSWIRE) — Agencia Comercial Spirits Ltd (the “Company” or “Agencia”) (Nasdaq: AGCC), a Taiwan-based specialized importer and distributor of high-quality whiskies, today announced the closing of its initial public offering (the “Offering”) of 1,750,000 Class A ordinary shares at a public offering price of US$4.00 per ordinary share (the